Company Filing History:
Years Active: 2009
Title: György Miklós Keserü: Innovator in Pharmacological Research
Introduction
György Miklós Keserü is a prominent inventor based in Telki, Hungary. He has made significant contributions to the field of pharmacology, particularly in the development of new therapeutic agents. His work focuses on addressing various mental health disorders and substance abuse issues.
Latest Patents
Keserü holds a patent for "Sulfonamide derivatives as D3-receptor ligands." This invention relates to new dopamine receptor subtype selective ligands that can be used in pharmacological compositions. The patent outlines their application in the therapy and prevention of psychoses, including schizophrenia and schizo-affective disorders. Additionally, it addresses drug abuse, cognitive impairments, and various psychological and neurological disorders.
Career Highlights
Keserü is associated with Richter Gedeon Vegyeszeti Gyar Rt, a leading pharmaceutical company in Hungary. His work has been instrumental in advancing the understanding of dopamine receptor interactions and their implications in mental health treatment. His innovative approach has led to the development of compounds that may significantly improve therapeutic outcomes for patients.
Collaborations
Throughout his career, Keserü has collaborated with notable colleagues, including János Galambos and Katalin Nógrádi. These partnerships have fostered a collaborative environment that enhances research and development efforts in pharmacology.
Conclusion
György Miklós Keserü is a key figure in the field of pharmacological research, with a focus on developing innovative solutions for complex mental health issues. His contributions through patents and collaborations continue to impact the pharmaceutical landscape positively.